Concerns Rise Over Weight Loss Medication Use and Marketing in Sweden

In Sweden, the growing use of weight loss medications has highlighted significant health risks and regulatory concerns. Patrick Rosengren, 59, spent 50,000 SEK on a weight loss drug, only to experience severe side effects while losing just 2.5 kg over a year, describing his ordeal as "completely insane." His experience underscores the potential dangers linked to these medications, which often come with serious side effects. Concurrently, several healthcare companies in Sweden have been offering subscriptions for these medications—priced between 299 and 995 kronor monthly with additional costs possibly reaching 8,000 kronor. Expert Claes Granmar warns that these marketing practices may violate Swedish drug laws and the Medical Association's guidelines, casting doubt on their legality and ethics. These issues emerge amid rising obesity rates in Sweden, with over one million adults now living with the condition, tripling since the 1980s. The Kristdemokraterna party advocates for stronger preventive measures, including a producer fee on sugary drinks and a national plan to promote healthy eating and physical activity, emphasizing the critical role of consistent doctor-patient relationships in supporting lifestyle changes. Together, these developments highlight a complex challenge balancing medication use, legal frameworks, and public health efforts in addressing obesity in Sweden.